Pheno.Ai provides advanced data solutions focused on phenotypic analysis. The platform leverages machine learning to process complex biological datasets for research and development applications. This service accelerates insights in areas like drug discovery and precision agriculture through robust data interpretation.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for identifying biomarkers and understanding human health rely on limited datasets that lack diversity, longitudinal data, and deep phenotyping, hindering the discovery of novel insights for diagnostics, prognostics, and therapeutics. Analyzing complex multi-omic data requires significant resources and expertise, creating a barrier to entry for many researchers and organizations.
Solution
Pheno.AI leverages the Human Phenotype Project (HPP), a large-scale, deep-phenotype, prospective longitudinal human health dataset, to derive insights for improving human health. The HPP collects data from a diverse global population of over 100,000 participants, both healthy and diseased, and follows them annually for 25 years. This extensive dataset enables the identification of novel molecular and other markers with significant diagnostic, prognostic, therapeutic, and preventative value. Pheno.AI provides AI models and tools to analyze this data, facilitating the development of wellness, healthcare, and systems biology insights.
Target Audience
The primary audience includes researchers, healthcare organizations, and wellness companies seeking to improve human health through data-driven insights and the identification of novel biomarkers.
Features
- Deep-phenotype multi-omic characterization for every participant profiled
- Longitudinal data collection, following participants annually for 25 years
- Data cleaned and documented, ready for research
- AI-driven analysis tools for biomarker discovery
- Diverse global participant population